Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.45 |
| ▸ | PLG | P00747 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2189282 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL2088486 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL380040 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL25288050 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL18911352 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL25293705 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL516952 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL25293609 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL14740539 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 | |
| SCHEMBL376691 | 1.00 | KMT2A (0.52) | KMT2ASOAT1MEN1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 803 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717733-A1 | POLYAMIDE RESIN COMPOSITION | UBE Corporation (JP) | 2026-04-01 | — | — | EP | claimed |
| EP-3725771-B1 | ALK PROTEIN DEGRADATION AGENT AND ANTI-TUMOR APPLICATION THEREOF | UNIV SHANGHAI TECHNOLOGY (CN) | 2026-02-04 | — | — | EP | claimed |
| EP-3762381-B1 | BIVALENT AGENTS COMPRISING A SERINE THREONINE KINASE (AKT) LIGAND COVALENTLY LINKED TO A DEGRADATION/DISRUPTION MOIETY FOR THE TREATMENT OF CANCER | ICAHN SCHOOL MED MOUNT SINAI (US) | 2025-05-07 | — | — | EP | claimed |
| CN-119327214-A | Emission reduction device for smelting copper-containing waste | 江西省金瑞环保科技有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119176763-A | Viscosity regulation method for reaction system for preparing chlorinated hydrocarbon dicarboxamide by chlorination of hydrocarbon dicarboxamide | 深圳有为技术控股集团有限公司 | 2024-12-24 | — | — | CN | claimed |
| WO-2024241685-A1 | POLYAMIDE RESIN COMPOSITION | ＵＢＥ株式会社 | 2024-11-28 | — | — | WO | claimed |
| WO-2024233871-A1 | ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION | LU FENG (US) | 2024-11-14 | — | — | WO | claimed |
| US-20240377729-A1 | ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION | LU FENG (US) | 2024-11-14 | — | — | US | claimed |
| CN-115701464-B | Super-hydrophobic finishing agent and preparation method and application thereof | 江苏金太阳纺织科技股份有限公司 | 2024-06-11 | — | — | CN | claimed |
| EP-3870589-B1 | SUBSTITUTED INDOLE DIMER COMPOUNDS | BRISTOL MYERS SQUIBB CO (US) | 2023-09-06 | — | — | EP | claimed |
| US-5015683-A | Acting radiation resistance | CIBA-GEIGY CORPORATION (US) | 1991-05-14 | — | — | US | claimed |
| EP-0389434-A1 | Bis(1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)-amine Derivatives and Stabilized compositions | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | claimed |
| WO-1990002137-A1 | RENIN INHIBITORY PEPTIDES CONTAINING SULEPTANIC ACID OR DERIVATIVES THEREOF | THE UPJOHN COMPANY (US) | 1990-03-08 | — | — | WO | claimed |
| EP-0181033-B1 | CONTROL FOR BLOOD GAS ANALYZERS AND HEMOGLOBIN ANALYSIS | AKZO N.V. (NL) | 1990-02-21 | — | — | EP | claimed |
| EP-0355065-A1 | Renin inhibitory peptides containing suleptanic acid or derivatives thereof | THE UPJOHN COMPANY (US) | 1990-02-21 | — | — | EP | claimed |
| US-4608246-A | Testing for a blood group immunological reaction | IMMUCOR, INC. (US) | 1986-08-26 | — | — | US | claimed |
| EP-0157797-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-10-16 | — | — | EP | claimed |
| WO-1985001354-A1 | DETECTING AN IMMUNOLOGICAL REACTION WITH ACTIVATED RED BLOOD CELLS (ERYTHROCYTES) | IMMUCOR, INC. (US) | 1985-03-28 | — | — | WO | claimed |
| EP-0000102-B1 | IMMUNOLOGIC COMPOSITIONS, METHODS FOR PREPARING THEM AND METHODS FOR CONDUCTING HAEMAGGLUTINATION TESTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-09-09 | — | — | EP | claimed |
| US-4115305-A | AMIDINE POLYMERS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1978-09-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240377729-A1 | ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION | NCLN, NCL, RPS13 | KMT2A 2202/4885SOAT1 396/4885MEN1 3411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.